| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | +68.3% |
| Cost of Revenue | $784K | +195.8% |
| Gross Profit | $1.8M | +42.2% |
| R&D Expense | $8.7M | +35.1% |
| SG&A Expense | $4.2M | +5.8% |
| Operating Income | -$13.4M | -17.8% |
| Pre-tax Income | -$8.3M | +31.4% |
| Net Income | -$8.3M | +31.4% |
| EPS (Basic) | -$2.22 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | -46.5% |
| Accounts Receivable | $685K | +108.8% |
| Inventory | $1.2M | +65.7% |
| Current Assets | $5.5M | -23.3% |
| Total Assets | $15.4M | -2.6% |
| Current Liabilities | $2.9M | -64.0% |
| Long-term Debt | $368K | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.1M | -37.5% |
| Capital Expenditures | $530K | -62.3% |
| Investing Cash Flow | -$501K | +54.5% |
| Financing Cash Flow | $11.7M | +251.0% |
| Free Cash Flow | -$14.6M | -25.5% |
| +95.9% |
| EPS (Diluted) | -$3.13 | +94.9% |
| Total Liabilities |
| $6.6M |
| -34.5% |
| Stockholders' Equity | $8.8M | +53.8% |